Lv1
92 积分 2024-08-27 加入
《血液肿瘤患者碳青霉烯类耐药肠杆菌科细菌（CRE）感染的诊治与防控中国专家共识（2025 年版）》
2天前
已完结
Normalizationoffastinghyperglycaemiabyexogenousglucagon-likepeptide1(7-36amide)intype2(non-insulin-dependent)diabeticpatient
6天前
已完结
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes
6天前
已完结
Holistic Impact of CKD: A Clinical, Economic, and Environmental Analysis by IMPACT CKD
28天前
已关闭
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
1个月前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study
1个月前
已完结
Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
1个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial
1个月前
已完结
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
1个月前
已完结
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
2个月前
已完结
皖公网安备34019202002308
